Advertisement

Trends in gestational age at delivery for intrahepatic cholestasis of pregnancy and adoption of society guidelines

      BACKGROUND

      Intrahepatic cholestasis of pregnancy is associated with a significant risk of stillbirth, which contributes to variation in clinical management. Recent Society for Maternal-Fetal Medicine guidance recommends delivery at 36 weeks of gestation for patients with serum bile acid levels of >100 μmol/L, consideration for delivery between 36 and 39 weeks of gestation stratified by bile acid level, and against preterm delivery for those with clinical features of cholestasis without bile acid elevation.

      OBJECTIVE

      This study aimed to investigate institutional practices before the publication of the new delivery timing recommendations to establish the maternal and neonatal effects of late preterm, early-term, and term deliveries in the setting of cholestasis.

      STUDY DESIGN

      This study examined maternal and neonatal outcomes of 441 patients affected by cholestasis delivering 484 neonates in a 4-hospital system over a 30-month period. Logistic and linear regression analyses were performed to assess neonatal outcomes concerning peak serum bile acid levels at various gestational ages controlling for maternal comorbidities, multiple pregnancies, and neonatal birthweight.

      RESULTS

      With the clinical flexibility afforded by the new guidelines, pregnancy prolongation to term may have been achieved in 91 patients (21%), and 286 patients (74%) with bile acid elevation could have delivered at a later gestational age. Preterm deliveries of patients with bile acid levels of >10 μmol/L were associated with higher rates of neonatal intensive care unit admission and adverse neonatal outcomes than early-term deliveries.

      CONCLUSION

      Study data suggested an opportunity for education and practice change to reflect current Society for Maternal-Fetal Medicine guidelines in efforts to reduce potential neonatal morbidities associated with late preterm deliveries among pregnancies affected by cholestasis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Clinical updates in women's health care summary: liver disease: reproductive considerations.
        Obstet Gynecol. 2017; 129: 236
        • Geenes V
        • Williamson C.
        Intrahepatic cholestasis of pregnancy.
        World J Gastroenterol. 2009; 15: 2049-2066
        • Bicocca MJ
        • Sperling JD
        • Chauhan SP.
        Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines.
        Eur J Obstet Gynecol Reprod Biol. 2018; 231: 180-187
        • MacDorman MF
        • Reddy UM
        • Silver RM.
        Trends in stillbirth by gestational age in the United States, 2006-2012.
        Obstet Gynecol. 2015; 126: 1146-1150
        • Puljic A
        • Kim E
        • Page J
        • et al.
        The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age.
        Am J Obstet Gynecol. 2015; 212: 667.e1-667.e5
        • Joshi D
        • James A
        • Quaglia A
        • Westbrook RH
        • Heneghan MA.
        Liver disease in pregnancy.
        Lancet. 2010; 375: 594-605
        • Qi HB
        • Shao Y
        • Wu WX
        • Zhang JH.
        Grading of intrahepatic cholestasis of pregnancy.
        Zhonghua Fu Chan Ke Za Zhi. 2004; 39: 14-17
        • Pataia V
        • Dixon PH
        • Williamson C.
        Pregnancy and bile acid disorders.
        Am J Physiol Gastrointest Liver Physiol. 2017; 313: G1-G6
        • Floreani A
        • Gervasi MT.
        New insights on intrahepatic cholestasis of pregnancy.
        Clin Liver Dis. 2016; 20: 177-189
        • Reyes H
        • Gonzalez MC
        • Ribalta J
        • et al.
        Prevalence of intrahepatic cholestasis of pregnancy in Chile.
        Ann Intern Med. 1978; 88: 487-493
        • Pusl T
        • Beuers U.
        Intrahepatic cholestasis of pregnancy.
        Orphanet J Rare Dis. 2007; 2: 26
        • Kawakita T
        • Parikh LI
        • Ramsey PS
        • et al.
        Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
        Am J Obstet Gynecol. 2015; 213: 570.e1-570.e8
        • Sengupta S
        • Carrion V
        • Shelton J
        • et al.
        Adverse neonatal outcomes associated with early-term birth.
        JAMA Pediatr. 2013; 167: 1053-1059
        • Jin J
        • Pan SL
        • Huang LP
        • Yu YH
        • Zhong M
        • Zhang GW.
        Risk factors for adverse fetal outcomes among women with early- versus late-onset intrahepatic cholestasis of pregnancy.
        Int J Gynaecol Obstet. 2015; 128: 236-240
        • Zhou L
        • Qi HB
        • Luo X.
        Analysis of clinical characteristics and perinatal outcome of early-onset intrahepatic cholestasis of pregnancy.
        Zhonghua Fu Chan Ke Za Zhi. 2013; 48: 20-24
        • Glantz A
        • Marschall HU
        • Mattsson LA.
        Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates.
        Hepatology. 2004; 40: 467-474
        • Brouwers L
        • Koster MP
        • Page-Christiaens GC
        • et al.
        Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels.
        Am J Obstet Gynecol. 2015; 212: 100.e1-100.e7
        • Ovadia C
        • Seed PT
        • Sklavounos A
        • et al.
        Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
        Lancet. 2019; 393: 899-909
        • Lee RH
        • Greenberg M
        • Metz TD
        • Pettker CM
        • Society for Maternal-Fetal Medicine (SMFM)
        Society for Maternal-Fetal Medicine Consult Series 53: intrahepatic cholestasis of pregnancy: replaces Consult #13, April 2011.
        Am J Obstet Gynecol. 2021; 224: B2-B9
        • Lo JO
        • Shaffer BL
        • Allen AJ
        • Little SE
        • Cheng YW
        • Caughey AB.
        Intrahepatic cholestasis of pregnancy and timing of delivery.
        J Matern Fetal Neonatal Med. 2015; 28: 2254-2258
        • Cui D
        • Zhong Y
        • Zhang L
        • Du H.
        Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: a meta-analysis.
        J Obstet Gynaecol Res. 2017; 43: 1411-1420
        • Raz Y
        • Lavie A
        • Vered Y
        • et al.
        Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies.
        Am J Obstet Gynecol. 2015; 213: 395.e1-395.e8